Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

218
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
218
Randomized Experiments01:13

Randomized Experiments

6.7K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
6.7K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

56
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
56
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

41
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
41
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

114
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
114
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

38
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
38

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Letrozole Alters Transcriptomic Profiles in Infrapatellar Fat Pad From Female Mice: Possible Involvement of Interleukins in Aromatase Inhibitor-Induced Arthralgias.

Journal of applied toxicology : JAT·2026
Same author

Assumption-Agnostic Deep Learning Framework for Holistic Clinical Trial Monitoring.

Therapeutic innovation & regulatory science·2026
Same author

Special issue on dose optimization.

Journal of biopharmaceutical statistics·2026
Same author

An Anti-Inflammatory and Pro-Angiogenic Porous Aloe Polysaccharide-Collagen Dressing Accelerates Wound Healing.

ACS applied bio materials·2025
Same author

M-DODII: Bayesian dose optimization design for randomized phase II study with multiple indications.

Journal of biopharmaceutical statistics·2025
Same author

Fruquintinib in less pretreated patients: Multivariate profile-matching analysis of FRESCO-2 to FRESCO.

European journal of cancer (Oxford, England : 1990)·2025
Same journal

Correction.

Journal of biopharmaceutical statistics·2026
Same journal

Leveraging external controls in clinical trials: estimands, estimation, assumptions.

Journal of biopharmaceutical statistics·2026
Same journal

Special issue of nonclinical statistics in regulatory applications guest editors' notes.

Journal of biopharmaceutical statistics·2026
Same journal

Comparison of flexible parametric modeling and nonparametric methods to estimate restricted mean survival time: A simulation study.

Journal of biopharmaceutical statistics·2026
Same journal

Simulated treatment comparisons with jackknife pseudo values for estimating population-adjusted marginal treatment effects.

Journal of biopharmaceutical statistics·2026
Same journal

Sample sizes for randomized controlled trials utilizing Bayesian response adaptive randomization for continuous outcomes.

Journal of biopharmaceutical statistics·2026
查看所有相关文章

相关实验视频

Updated: May 28, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.4K

贝叶斯模型对多种适应症的随机剂量优化试验的平均值.

Wei Wei1, Jianchang Lin2

  • 1Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA.

Journal of biopharmaceutical statistics
|February 11, 2025
PubMed
概括
此摘要是机器生成的。

这项研究引入了贝叶斯模型平均方法,用于瘤学剂量检测试验. 这种方法通过学习多种适应症来提高剂量推的准确性,为传统方法提供了替代方案.

关键词:
有针对性的治疗.有关信息的先行者.总体协议的总体协议项目是最优的项目.

更多相关视频

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
00:04

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.6K
A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM
13:54

A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM

Published on: August 18, 2023

4.4K

相关实验视频

Last Updated: May 28, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.4K
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
00:04

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.6K
A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM
13:54

A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM

Published on: August 18, 2023

4.4K

科学领域:

  • 在瘤学瘤学.
  • 临床试验设计 临床试验设计
  • 生物统计学 生物统计学

背景情况:

  • 传统的瘤学剂量检测试验面临着针对性药物的挑战,往往导致毒性而不提高疗效.
  • 在多种指示的概念验证试验中,优化针对性药物的剂量是复杂的,因为患病率很低,需要特定于指示的剂量-反应表征.

研究的目的:

  • 提出一个新的贝叶斯模型平均方法,使用强大的混合先验 (rBMA).
  • 在同时进行的随机化剂量优化研究中确定推的III期剂量.
  • 为瘤学剂量发现提供"更多是更好的"范式的替代方案.

主要方法:

  • 开发了一种贝叶斯模型平均方法,具有强大的混合先验 (rBMA).
  • 应用于随机化剂量优化研究的方法,这些研究同时在多种适应症中进行.
  • 进行系统的模拟研究以评估性能.

主要成果:

  • 拟议的rBMA方法提高了剂量建议的准确性,而不是独立的适应症特定策略.
  • 该模型有效地学习各种适应症,提高剂量检测精度.
  • 模拟研究证实了该方法在做出正确剂量建议方面的表现.

结论:

  • 该rBMA方法提供了一个更准确和更有效的方法,用于在多种指示的瘤学试验中优化剂量.
  • 这种贝叶斯策略为针对性药物提供了一种可行的替代方案,而不是传统的剂量查找范式.
  • 交叉指示学习提高了推的第三阶段剂量的可靠性.